SANUWAVE HEALTH INC - SNWV STOCK NEWS

SANUWAVE Health, Inc. (OTC PINK:SNWV) has announced its participation in the Microcap Rodeo's Windy City Roundup 2022 conference, taking place on October 12-13, 2022. The company will present a live investor session on October 13 at 10:30 AM (CT), with a replay available shortly after. Investors can access the presentation through SANUWAVE's investor portal. The conference will feature over 60 microcap companies, providing insights into potential investment opportunities and trends for 2023.

SANUWAVE Health announces the appointment of Dr. Toni Rinow as Chief Financial Officer, effective immediately. Dr. Rinow brings over 20 years of experience in corporate development, focusing on growth and revenue acceleration. She has previously raised over $130 million for a NASDAQ-traded wellness company. CEO Kevin Richardson emphasized that her experience aligns strategically with SANUWAVE's goals post-financing. The company is dedicated to advancing non-invasive wound care technologies that enhance natural healing processes.

SANUWAVE Health, Inc. (OTCPK: SNWV) reported significant second-quarter results for 2022, with revenues of $3.9 million, marking a 33% increase from 2021. The company successfully placed over 50 wound care systems, doubling from the previous year, and administered over 40,000 wound treatments. Gross margin improved to 72% from 64%. Operating loss decreased to $2 million vs. $4 million in 2021. SANUWAVE became current with SEC filings and is positioned for profitable growth in wound care.

SANUWAVE Health (OTCQB: SNWV) has aided football legend Jim McMahon in recovering from complications due to a surgical infection using their ENERGY FIRST devices, dermaPACE® and UltraMIST®. Following his surgery in November 2021, McMahon faced healing delays, prompting the need for effective treatment. SANUWAVE's combination therapy, initiated on April 27, 2022, successfully addressed his wound, which was healed within three weeks. Kevin Richardson, CEO, expressed pride in their technology's impact on improving wound care.

SANUWAVE Health (SNWV) reported a 75% increase in estimated revenue for June year-over-year, attributed to heightened recurring revenue and successful conversions from evaluations. The sales funnel rose by 9% to $23 million, and system trials grew by 5%, totaling 109 trials. The company is closely monitoring these figures for the second quarter and expects some volatility ahead. This positive trend in sales metrics underlines SANUWAVE's commitment to enhancing its wound care portfolio.

SANUWAVE Health (OTC: SNWV) announced a strong performance for May 2022, reporting an estimated revenue increase of 96% year-over-year. The sales funnel also saw a 5% increase, totaling $21.1 million, while system trials rose by 2%, reaching 103 active trials. These trends suggest significant growth potential for the second quarter, although the company anticipates some volatility in these figures going forward. SANUWAVE specializes in innovative wound care and regenerative medicine, focusing on non-invasive medical systems.

SANUWAVE Health reported a significant 100% revenue increase year-over-year for Q1 2022, totaling $3.2 million, up from $2.1 million in 2021. The first quarter's sales were driven by their ENERGY FIRST device line, as the prior year's biologics sales are no longer included. Additionally, April saw a 9% increase in the sales funnel, reaching $19.9 million, while system trials rose 5% to 101. Despite potential volatility, these metrics provide visibility into future revenue growth as the company navigates opportunities in the wound care market.

SANUWAVE Health (SNWV) announced the issuance of several new patents in 2022, enhancing its innovative technology portfolio for advanced wound care and industrial applications. The newly issued patents include innovations in shockwave and ultrasound technologies, with a total of 160 patents now active. Notable patents involve methods for oil separation, tissue disinfection, and underwater cleaning using shockwaves. The company aims to leverage this intellectual property to enhance its competitive edge and explore partnership opportunities, further solidifying its position in both medical and non-medical sectors.

SANUWAVE Health, Inc. (SNWV) announced the addition of three new members to its board of directors, effective Q2 2022. The new members, Ian Miller, Jeffrey Blizard, and Jim Tyler, bring extensive experience in sales and operations within the healthcare industry. CEO Kevin Richardson expressed optimism about the company's growth potential for 2022. The announcement also noted gratitude for departing board member John Nemelka, who has significantly contributed to the company for over 17 years. SANUWAVE focuses on innovative wound care products and regenerative medicine technologies.